Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold L Atkins

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|January 12, 2019
Another brick in the wall: further evidence supporting the role of haematopoietic stem cell transplantation in treating multiple sclerosisHarold L Atkins
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2016
Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - YESMark Freedman, Harold L Atkins
Oncolytic Virotherapy|August 12, 2016
The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implicationsJovian J Tsang, Harold L Atkins
Neurology|January 28, 2004
Suppressing immunity in advancing MS: too much too late, or too late for much?Mark S Freedman, Harold L Atkins
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 30, 2012
Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learnedHarold L Atkins, Mark S Freedman
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 20, 2017
Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple SclerosisHarold L Atkins, Mark S Freedman
Cold Spring Harbor Perspectives in Medicine|April 4, 2018
Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple SclerosisCarolina A Rush, Harold L Atkins, Mark S Freedman
Multiple Sclerosis and Related Disorders|April 26, 2021
A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosisGauruv Bose, Carolina Rush, Harold L Atkins, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 26, 2018
Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosisGauruv Bose, Harold L Atkins, Marjorie Bowman, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2022
CLIPPERS Responsive to Cladribine as a Durable Steroid-Sparing AgentSimon Thebault, Hailey Bergman, Harold L Atkins, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Neurology, Neurosurgery, and Psychiatry|January 12, 2019
Another brick in the wall: further evidence supporting the role of haematopoietic stem cell transplantation in treating multiple sclerosisHarold L Atkins
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2016
Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - YESMark Freedman, Harold L Atkins
Oncolytic Virotherapy|August 12, 2016
The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implicationsJovian J Tsang, Harold L Atkins
Neurology|January 28, 2004
Suppressing immunity in advancing MS: too much too late, or too late for much?Mark S Freedman, Harold L Atkins
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 30, 2012
Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learnedHarold L Atkins, Mark S Freedman
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 20, 2017
Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple SclerosisHarold L Atkins, Mark S Freedman
Cold Spring Harbor Perspectives in Medicine|April 4, 2018
Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple SclerosisCarolina A Rush, Harold L Atkins, Mark S Freedman
Multiple Sclerosis and Related Disorders|April 26, 2021
A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosisGauruv Bose, Carolina Rush, Harold L Atkins, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 26, 2018
Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosisGauruv Bose, Harold L Atkins, Marjorie Bowman, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2022
CLIPPERS Responsive to Cladribine as a Durable Steroid-Sparing AgentSimon Thebault, Hailey Bergman, Harold L Atkins, et al.
Pageof 5